Research Options:
Week of Expected Pricing Withdrawn
Company Name CENTREXION THERAPEUTICS CORP
Proposed Ticker CNTX
CUSIP 15643W100
Business Description A late clinical-stage biopharmaceutical company focused on becoming the leader in identifying, developing and commercializing novel, non-opioid and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain
Lead Underwriter Credit Suisse Securities (USA) LLC, SVB Leerink LLC
Co-Managers N/A
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.